A new review published in August 2018, in the Journal Brain Sciences looked at the effectiveness of the ketogenic diet to treat adult epilepsy, adult malignant glioma (brain tumors), and Alzheimer’s disease. It was written by Tanya J. W. McDonald and Mackenzie C. Cervenka from the Department of Neurology, Johns Hopkins University School of Medicine. The review is titled "The Expanding Role of Ketogenic Diets in Adult Neurological Disorders." The aim of the review is to describe the evidence, preclinical and clinical, supporting Ketogenic Diet use in the management of adult epilepsy, adult malignant gliomas (brain tumors), and Alzheimer’s disease. Several randomized controlled trials support the use of Ketogenic Diets for the treatment of drug-resistant epilepsy and there is emerging evidence that these diets are also effective in treating refractory status epilepticus, malignant glioma and Alzheimer’s disease in adults.
There have been several studies from countries outside the U.S. that show the health virtues of coconut oil for Alzheimer's Disease. Meanwhile, pronouncements from the USA’s Alzheimer's Association and medical press releases, warning against using coconut oil, have persisted. These international studies conclusions fly in the face of our “expert” opinions that, as a saturated fat, coconut oil threatens heart health. This misinformation continues even as medical practitioners of all types are realizing that the lipid theory of heart disease as the leading contributor to poor heart health is simply not true. The most recent study was published on July 20th, by the Journal of Alzheimer's Disease. This human study was conducted by academic researchers in Valencia, Spain, and titled Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study. This was a remarkable study, as there were measurable improvements among Alzheimer's patients in 21 days from adding coconut oil to a Mediterranean diet.
Another study has been published here in 2018 looking at the positive effects of virgin coconut oil for Alzheimer's disease. This is the third peer-reviewed study we have covered so far in 2018 looking at the effects of coconut oil on Alzheimer's Disease (AD). This latest study is titled "Possible prophylactic anti-excitotoxic and anti-oxidant effects of virgin coconut oil on aluminium chloride-induced Alzheimer's in rat models." It was published July 13, 2018, in the "Journal of Integrative Neuroscience." The study was conducted by researchers from the Faculty of Medicine at King Abdulaziz University in Saudi Arabia. This year's previous studies on AD and coconut oil were also conducted outside of the U.S. (Japan and Iran.) This study is significant, because it addresses the issue of aluminum toxicity, which has been increasingly linked to AD. (See: Study: High Amounts of Aluminum in Brains of Alzheimer’s Patients.) From the study abstract: "Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects an estimated 5.4 million people worldwide. However, there remains no curative treatment for the condition. Aβ and hyperphosphorylated tau accumulation are the main hallmarks of the disease; they interfere with glutamate uptake and mediate glutamate excitotoxicity, oxidative stress, inflammation and neurodegeneration. As virgin coconut oil (VCO) is well-known as an antioxidant and anti-inflammatory natural compound, the purpose of the present study was to assess the possible prophylactic effect of VCO on aluminium chloride (AlCl3)- induced AD in rat."
Scottish medical doctor, Malcolm Kendrick, has just written a brilliant expose on his blog explaining, scientifically, why it is impossible for saturated fats to raise LDL cholesterol levels. As I have written many times over the years, this is the kind of information that can save your life and help you make wise dietary choices, but it is information that the U.S. government, Big Pharma, and the corporate-sponsored "mainstream" media cannot afford to publish. Because to do so would be to admit guilt in one of the biggest medical scams of all time: the lipid theory of heart disease. This theory, which has been proven scientifically to be false, has been an economic success for cholesterol-lowering statin medical drugs, the most profitable class of medical drugs all time. This theory also promotes the low-fat diet which encourages consumption of carbohydrates from U.S. subsidized crops, as well as polyunsaturated oil, also derived from U.S. subsidized crops. This theory of heart disease, which condemns cholesterol and saturated fat, has probably been responsible for many millions of people's early deaths and the life-long suffering of autoimmune diseases for an entire generation.
Last month (May, 2018) I wrote about a new study published in Iran that looked at the "neuroprotective effects" effects of virgin coconut oil for Alzheimer's patients. The title of the study is Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat and was published in the journal Food and Chemical Toxicology. While we have been publishing reports of coconut oil reversing the symptoms of Alzheimer's Disease and other neurological diseases for several years now, we believe this was the first peer-reviewed study to actually look at some of the mechanisms of how coconut oil benefits Alzheimer's patients. Now, a second peer-reviewed study has been published here in 2018 looking at the mechanisms of how coconut oil positively affects Alzheimer's patients. Published in the journal, Neurochemical Research, researchers in Japan examined the effects of lauric acid, the most predominant medium chain fatty acid found in coconut oil, on activated microglia in mice. Coconut oil is nature's richest source of lauric acid at about 50% of its composition, and human breast milk comes in a distant second at around 6% lauric acid. The title of the study is Lauric Acid Alleviates Neuroinflammatory Responses by Activated Microglia: Involvement of the GPR40-Dependent Pathway.
A new study, published by the BMJ (British Medical Journal) in May 2018, found that people consuming eggs regularly were less at risk for heart disease than those who consumed no eggs. The title of the Chinese study is Associations of egg consumption with cardiovascular disease in a cohort study of 0.5 million Chinese adults. Over a half-million Chinese, between the ages of 30 and 79, were recruited across various regions of China and surveyed for egg consumption. Those with histories of cancer, heart disease, stroke, or diabetes were excluded from the study. Those remaining, slightly under a half-million, were followed for several years to determine incidents of cardiovascular disease (CVD) and both ischemic and hemorrhagic strokes. The average egg consumption varied from none to over one a day. The study’s conclusion: "Our findings suggested that daily egg consumption (<1 egg) [actually .8 daily on average] was associated with lower risk of CVD [cardiovascular disease], IHD [ischemic heart disease], MCE [major coronary events], hemorrhagic stroke and ischaemic stroke among Chinese middle-aged adults. Our findings contribute scientific evidence to the dietary guidelines with regard to egg consumption for the healthy Chinese adult." The study noted that morbidity from strokes is higher in China than Western nations where deaths from ischemic heart disease (ISD) are higher. An average egg consumption of .8 could translate to five to six eggs per week. The Chinese study also referenced an earlier smaller Japanese study, the Life Span Study in Japan, and found that “daily egg consumption was associated with a 30% lower risk of total stroke mortality” compared to no or occasional consumption of eggs.
Big Pharma Cannot Explain Why People with Very High LDL Cholesterol Have No Cardiovascular Disease and Live Long Lives
If your hypothesis is that all swans are white, the discovery of one black swan refutes your hypothesis. That is how science works. Or at least that is how science should work. In the real world, scientists are highly adept at explaining away contradictions to their favoured hypotheses. They will use phrases such as, it’s a paradox, or inform you that you didn’t measure the correct things or say there are many other confounding factors – and suchlike. Anyway, accepting that the finding of someone with a very high LDL level, and no detectable atherosclerosis, will always be dismissed – in one way or another – I am still going to introduce you to a ‘case history’ of a seventy-two-year-old man with familial hypercholesterolaemia, who has been studied for many, many, years. Try as they might, the researchers have been unable to discover any evidence for cardiovascular disease (CVD) – of any sort. The paper was called ‘A 72-Year-Old Patient with Longstanding, Untreated Familial Hypercholesterolemia but no Coronary Artery Calcification: A Case Report.’ And just in case you believe this is a single outlier, something never seen before or since, let me introduce you to the Simon Broome registry, set up in the UK many years ago to study what happens to individuals diagnosed with familial hypercholesterolaemia (FH). It is the longest, if not the largest, study on FH in the world. It has mainly been used as one of the pillars in support of the cholesterol hypothesis. However, when you start to look closely at it – fascinating things emerge. One of the most interesting is that people with FH have a lower than expected overall mortality rate – in comparison to the ‘normal’ population. Or, to put this another way. If you have FH, you live longer than the average person.
Study: Virgin Coconut Oil Reduces Aβ Plaques, Inflammation, and Oxidative Stress Associated with Alzheimer’s Disease
A study just published in August 2018 in the journal Food and Chemical Toxicology confirms what many people have already discovered: coconut oil can improve or even reverse the effects of Alzheimer's Disease. This is believed to be the first peer-reviewed study to examine coconut oil's effect on Alzheimer's Disease. The title of the study is "Virgin coconut oil (VCO) by normalizing NLRP3 inflammasome showed potential neuroprotective effects in Amyloid-β induced toxicity and high-fat diet fed rat." Researchers from Kermanshah University of Medical Sciences and Hamadan University of Medical Sciences in Iran used rats in a laboratory to study "the effects of virgin coconut oil (VCO) on inflammasome and oxidative stress in an Alzheimer's model." Their study found that the rats fed VCO "improved hippocampus histological changes, reduced Aβ plaques and phosphorylated Tau." (Phosphorylated Tau is a biological marker for Alzheimer's Disease.) They concluded that virgin coconut oil "showed potential neuroprotective effects." From the study conclusion: "Virgin Coconut Oil improves the health of the hippocampus and improves memory and learning in Alzheimer and HFD model rats by inhibiting inflammasome and reducing oxidative stress."
The failure of Big Pharma to develop an Alzheimer's drug has been well-documented in the corporate-sponsored "mainstream" media. As Alzheimer's diagnoses continue to increase, drug companies are scrambling to develop the next big drug to market to seniors. In modern times, the most successful drugs in sales, so far, have been cholesterol-lowering statin drugs, as one out of every five people over the age of 50 are now taking drugs to lower one's cholesterol, raking in billions of dollars for pharmaceutical companies. The sick irony to this is that lowering one's cholesterol artificially is directly linked to declining cognitive health and diseases such as Alzheimer's, since 25% of one's total cholesterol is located in the brain. The failed scientific hypothesis behind these drugs is that cholesterol is a cause of heart disease, and that diets high in saturated fats contribute to high cholesterol. However, the actual science shows almost the opposite, and when one looks at death rates, for example, lower cholesterol rates do not equate to longer life - in fact the converse is true: higher cholesterol levels lead to longer life spans. The pharmaceutical industry and the U.S. government cannot afford to reverse their warnings against saturated fats and cholesterol, however, as it would be the same as confessing that the entire statin drug industry has been a scam, and that statin drugs actually cause more harm than good. This is the main reason why the USDA must continue supporting a low-fat diet and condemning saturated fats, even though the science does not support their positions. It is no surprise, therefore, to learn that peer-reviewed scientific studies continue to show that the high-fat ketogenic diet supports cognitive health and can help prevent or reduce cognitive diseases such as Alzheimer's. Here are four new studies just published on the high-fat ketogenic diet related to cognitive health, and preventing Alzheimer's Disease.
With the rise of antibiotic resistant pathogens, researchers are turning their attention to natural products in hopes of finding cures outside of the patented pharmaceutical paradigm for fighting disease. In a study just published in Journal of Applied Microbiology, Australian researchers studied 22 natural products and their ability to inhibit the spore cycle of Clostridium difficile. Clostridium difficile (C. diff) is mostly incubated in hospital settings, is antibiotic resistant, and very contagious. It can create life-threatening inflammation of the colon. The Australian researchers tested 22 natural products in vitro, and found that three of them "showed inhibitory effects on sporulation of C. difficile. Effects on sporulation, determined using microscopy and a conventional spore recovery assay, showed that fresh onion bulb extract (6.3% v v-1 ) and coconut oil (8% v v-1 ) inhibited sporulation in all four isolates by 66-86% and 51-88%, respectively, compared to untreated controls. Fresh ginger rhizome extract (25% v v-1 ) was also inhibitory, although to a lesser extent."